Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Dec;15 Suppl 6(Suppl 6):s92-6.
doi: 10.7861/clinmedicine.15-6-s92.

Recent advances in the pathogenesis and treatment of osteoporosis

Elizabeth M Curtis  1 , Rebecca J Moon  2 , Elaine M Dennison  1 , Nicholas C Harvey  3 , Cyrus Cooper  4
Affiliations
Review

Recent advances in the pathogenesis and treatment of osteoporosis

Elizabeth M Curtis et al. Clin Med (Lond). 2015 Dec.

Abstract

Over recent decades, the perception of osteoporosis has changed from that of an inevitable consequence of ageing, to that of a well characterised and treatable chronic non-communicable disease, with major impacts on individuals, healthcare systems and societies. Characterisation of its pathophysiology from the hierarchical structure of bone and the role of its cell population, development of effective strategies for the identification of those most appropriate for treatment, and an increasing armamentarium of efficacious pharmacological therapies, have underpinned this evolution. Despite this marked progress, individuals who experience a fragility fracture remain under-treated in many areas of the world, and there is substantial need for investment both in secondary and primary prevention globally. In this brief article, we give an overview of the pathogenesis of osteoporosis, and summarise current and future approaches to its assessment and treatment.

Keywords: dxa; epidemiology; osteoporosis; pathophysiology; risk assessment; ­treatment.

PubMed Disclaimer

References

    1. van Staa TP, Dennison EM, Leufkens HG, Cooper C. Epidemiology of fractures in England and Wales. Bone. 2001 Dec;29(6):517–22. Epub 2001/12/01. eng. - PubMed
    1. Hernlund E, Svedbom A, Ivergard M, Compston J, Cooper C, Stenmark J, et al. Osteoporosis in the European Union: medical management, epidemiology and economic burden : A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA) Archives of osteoporosis. 2013 Dec;8(1–2):136. Epub 2013/10/12. eng. - PMC - PubMed
    1. Saito M, Marumo K. Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int. 2010 Feb;21(2):195–214. Epub 2009/09/18. eng. - PubMed
    1. Boskey A. Bone mineral crystal size. Osteoporos Int. 2003 Sep;14(Suppl 5):S16–20. discussion S-1. Epub 2003/09/25. eng. - PubMed
    1. Hernandez CJ, Beaupre GS, Carter DR. A theoretical analysis of the relative influences of peak BMD, age-related bone loss and menopause on the development of osteoporosis. Osteoporos Int. 2003;14(10):843–7. - PubMed

Publication types